Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis. - Wikidata - wikimedia - TriplyDB

Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis.

Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis.

http://www.wikidata.org/entity/Q39213379

about

To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses Trial Watch:: Oncolytic viruses for cancer therapy Oncolytic viruses as anticancer vaccines Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response.Measles to the Rescue: A Review of Oncolytic Measles Virus Viral oncolysis - can insights from measles be transferred to canine distemper virus?Success of measles virotherapy in ATL depends on type I interferon secretion and responsiveness.Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors.Oncolysis by paramyxoviruses: preclinical and clinical studies.Inhibition of translation by IFIT family members is determined by their ability to interact selectively with the 5'-terminal regions of cap0-, cap1- and 5'ppp- mRNAs.Oncolytic viruses and their application to cancer immunotherapy Antitumor Virotherapy by Attenuated Measles Virus (MV).STAT1 and NF-κB Inhibitors Diminish Basal Interferon-Stimulated Gene Expression and Improve the Productive Infection of Oncolytic HSV in MPNST Cells.Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma.Clonal variation in interferon response determines the outcome of oncolytic virotherapy in mouse CT26 colon carcinoma model.Interferon-Mediated Tumor Resistance to Oncolytic Virotherapy.Oncolytic Viruses-Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer Cap-dependent translational control of oncolytic measles virus infection in malignant mesothelioma.Measles Vaccine.Tumor Restrictions to Oncolytic Virus.Engineered Oncolytic Poliovirus PVSRIPO Subverts MDA5-Dependent Innate Immune Responses in Cancer Cells

P2860

Q26767212-DB787C4C-7984-4C36-8763-3CDB7C4954DF Q27021951-E39FDA44-EF9C-4786-9581-CD3165E7BE28 Q27025600-59DC29F1-889C-4986-910D-3FBC1DE63EED Q27340224-B7CCF801-1E7A-4C1B-8979-EE0A614AD917 Q28072097-E4DC92C2-2334-4723-A086-91F22A551276 Q33820717-A4A82393-B432-494C-898B-BB2C1AF82CA2 Q34053730-E80E2A22-EF4E-49A7-AE3C-2DB25E3C0C11 Q35111983-8A91CB3A-E955-43B9-B553-4CE5DB4739B2 Q35861933-EC94A811-F552-4640-AEE5-9B32623D89F2 Q37631859-F828BD18-41B6-48BF-A5FA-1E735027DF2B Q38207011-6D8C5F82-36B7-4144-A97A-C3E86E757867 Q38212137-859E4C4D-AEC5-4BDC-8488-B4A2F817B0D3 Q38793802-CB78A416-A815-4EB6-A078-95640D5B23FC Q38845173-AC80E4A4-8979-462D-9916-1E6DBE25C0BE Q38955561-814717D2-B9FC-4203-B3F8-585D107CDB00 Q39109430-1666CC5B-F466-43CA-9BF2-F26271B15D1A Q41699675-5DE92289-5778-494D-9F72-5144F403DC1E Q41926374-E5BB930F-E4B1-4287-816C-A57EF0BE8643 Q46300761-0AD08D8F-13CD-48AB-B874-00E6D2ECAF50 Q51846287-DBF4CB6C-65BA-4842-8A4E-067AC9E189E1 Q57753028-B53A3C1D-906F-4DD4-9FB3-39A0D270350D

P2860

Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis.

http://www.wikidata.org/entity/Q39213379

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Innate immune defense defines ...... vaccine virus-based oncolysis.

@en

Innate immune defense defines ...... vaccine virus-based oncolysis.

@nl

type

label

Innate immune defense defines ...... vaccine virus-based oncolysis.

@en

Innate immune defense defines ...... vaccine virus-based oncolysis.

@nl

prefLabel

Innate immune defense defines ...... vaccine virus-based oncolysis.

@en

Innate immune defense defines ...... vaccine virus-based oncolysis.

@nl

P1433

Q39213379-8E04E5FC-A349-428C-9C9E-E87A7D472195

P1476

Q39213379-96497E1B-91F2-4CCC-B82A-93A77891F741

P2093

Q39213379-0044E5CF-9FA5-4D4D-89D3-9930177ED257

Q39213379-13857A65-D86F-417F-AA6E-FFD29006FAAF

Q39213379-16F66137-DAE3-4730-B412-74429BEE4692

Q39213379-21678F64-53D9-4B37-A16D-111496E8D605

Q39213379-2721A381-2A93-4CC3-BBC8-4F16657C15BE

Q39213379-894117D3-6667-4C89-840F-C7BF499CC21F

Q39213379-A44C1133-6D0D-4B67-9C17-BC03272B5CCC

Q39213379-ACFA3829-E22C-48BD-922C-D4578789B5E1

Q39213379-B893D437-BA09-47CA-918B-54925BA991F5

Q39213379-B903DDD4-0FAD-4696-B5F1-B0A9323FEF27

P2860

Q39213379-04C54D70-5E50-4802-A997-E01915A417FC

Q39213379-0692B0FC-31FC-402E-BB73-5760829C13D9

Q39213379-1095A225-34D2-4E38-AF20-9DF044594F9F

Q39213379-1EFFDFE2-782F-4796-852E-1F2038BEE366

Q39213379-25DC283C-EB5D-4F1F-A029-0D8246C06216

Q39213379-2A4ECD70-6237-435D-8AEE-FFB59CCC71E4

Q39213379-31049C26-1891-42FE-A75F-25106B2E4253

Q39213379-3AF1CB49-9909-475A-BE40-8C38E7E2E0CD

Q39213379-3EEA33F5-4FEC-48BF-8BB5-ACB3904DAD34

Q39213379-40C777B9-742F-4CDC-A7DB-678A72F87F9F

P304

Q39213379-0BAF121E-06B7-412F-8BDE-81FD3A99189A

P31

Q39213379-4798593A-9AE9-46C8-BEC4-FE153E5E37D6

P356

Q39213379-4ED12F5D-4E27-4F6B-9279-9F41BBADB85A

P407

Q39213379-FBDE4890-639E-4BFA-80C4-5011A495CE8A

P433

Q39213379-7D257169-F6CB-4B27-846D-BA566603E094

P478

Q39213379-1DFCFA59-9942-4880-B7E2-F392CE7B3368

P577

Q39213379-A91D6A9C-8845-4DDA-B796-6C5A02CF6988

P5875

Q39213379-53544261-4DE7-41CB-AB3D-DA94368CD3DB

P698

Q39213379-00852E1E-377D-40FC-8A5D-5B22C5BEEB36

P921

Q39213379-1110139F-67A5-4324-ACE5-6E7F91D05DEE

P932

Q39213379-5228B0F4-B9CD-40D7-80E0-3B582CC82069

P356

P1433

Journal of Virology

P1476

Innate immune defense defines ...... vaccine virus-based oncolysis.

@en

P2093

Frank Stubenrauch

http://www.w3.org/2001/XMLSchema#string

Hans-Georg Kopp

http://www.w3.org/2001/XMLSchema#string

Irina Smirnow

http://www.w3.org/2001/XMLSchema#string

Jeanette Reiser

http://www.w3.org/2001/XMLSchema#string

Johanna Lampe

http://www.w3.org/2001/XMLSchema#string

Michael Bitzer

http://www.w3.org/2001/XMLSchema#string

Nisar P Malek

http://www.w3.org/2001/XMLSchema#string

Nora Mayer

http://www.w3.org/2001/XMLSchema#string

Rupert Handgretinger

http://www.w3.org/2001/XMLSchema#string

Sabine Schleicher

http://www.w3.org/2001/XMLSchema#string

P2860

IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA

Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus.

Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1

Measles virus V protein is a decoy substrate for IkappaB kinase alpha and prevents Toll-like receptor 7/9-mediated interferon induction

STAT2 is a primary target for measles virus V protein-mediated alpha/beta interferon signaling inhibition

Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication

Paramyxovirus V proteins interact with the RNA Helicase LGP2 to inhibit RIG-I-dependent interferon induction

Both RIG-I and MDA5 RNA Helicases Contribute to the Induction of Alpha/Beta Interferon in Measles Virus-Infected Human Cells

A new mathematical model for relative quantification in real-time RT-PCR

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

P304

3484-3501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.02106-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234098582

http://www.w3.org/2001/XMLSchema#string

P698

23302892

http://www.w3.org/2001/XMLSchema#string

P921

P932

3592150

http://www.w3.org/2001/XMLSchema#string